U.S. to defer 33M Covid vaccine doses to Africa

Brasil Notícia Notícia

U.S. to defer 33M Covid vaccine doses to Africa
Brasil Últimas Notícias,Brasil Manchetes
  • 📰 politico
  • ⏱ Reading Time:
  • 10 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 7%
  • Publisher: 59%

The U.S. will defer delivery of roughly 33 million doses of Moderna's Covid-19 vaccine so that they can be purchased by the African Union

"This deal will get the continent Moderna doses that have been long-awaited and in high demand," said White House press secretary Jen Psaki.The United States will defer delivery of roughly 33 million doses of Moderna's Covid-19 vaccine so that they can be purchased by the African Union, the White House announced Tuesday.

The U.S. doses are scheduled to be deferred between December 2021 and February 2022, "so that the African Union can instead purchase and take delivery of those doses," she said.

Resumimos esta notícia para que você possa lê-la rapidamente. Se você se interessou pela notícia, pode ler o texto completo aqui. Consulte Mais informação:

politico /  🏆 381. in US

Brasil Últimas Notícias, Brasil Manchetes

Similar News:Você também pode ler notícias semelhantes a esta que coletamos de outras fontes de notícias.

Moderna Reports COVID-19 Vaccine Safe and Efficacious for KidsModerna Reports COVID-19 Vaccine Safe and Efficacious for KidsThe company plans to submit a request to authorize the vaccine for children ages 6 to 11 years old
Consulte Mais informação »

Moderna says its Covid vaccine has strong results in children ages 6 to 11Moderna says its Covid vaccine has strong results in children ages 6 to 11Data from an interim study showed two 50 microgram doses of the vaccine, half the strength of the doses used in the vaccine given to adults, generated virus-neutralizing antibodies in children.
Consulte Mais informação »

Moderna says its COVID-19 vaccine protective, safe in young childrenModerna says its COVID-19 vaccine protective, safe in young childrenModerna Inc said on Monday its COVID-19 vaccine generated a strong immune response and was generally well-tolerated in children aged six to 11 years, and the company plans to submit the data to regulators soon.
Consulte Mais informação »

Moderna says its low-dose COVID shot works for kids 6 to 11Moderna says its low-dose COVID shot works for kids 6 to 11Moderna said Monday that a low dose of its COVID-19 vaccine is safe and appears to work in 6- to 11-year-olds, as the manufacturer moves toward expanding shots to children. Competitor Pfizer's kid-sized vaccine doses are closer to widespread use, undergoing evaluation by the Food and Drug Administration for nearly the same age group — starting at age 5.
Consulte Mais informação »

Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna says its COVID-19 vaccine is protective, safe in kids 6 to 11Moderna said its two-dose vaccine generated virus-neutralizing antibodies in children and safety was comparable to what was previously seen in clinical trials of adolescents and adults.
Consulte Mais informação »

Moderna Says Its Low-Dose COVID-19 Vaccine Works For Kids 6 To 11Moderna Says Its Low-Dose COVID-19 Vaccine Works For Kids 6 To 11Children who received the vaccine developed virus-fighting antibodies similar to levels that young adults produce after full-strength shots, Moderna said.
Consulte Mais informação »



Render Time: 2025-03-11 02:21:22